adc vaccine
VaccineexperimentalCOVID-19
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 31, 2020 (NCT04487756)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04487756 | Phase 1/Phase 2 (Phase 2) | Oct 31, 2020 | Institute of Oncology Dr. Rosell (IOR), Roche, University Hospital Quirón Dexeus, Barcelona, University of Barcelona |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Institute of Oncology Dr. Rosell (IOR) | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Roche | For profit | 1 | 0 | 1 | 2020 |
| University Hospital Quirón Dexeus, Barcelona | Academic/Hospital | 1 | 0 | 1 | 2020 |
| University of Barcelona | Academic/Hospital | 1 | 0 | 1 | 2020 |
4 organizations
Page 1 / 1